Date:8/15/2011

enses for the quarter totaled $967,000, an increase of 58%, compared with $612,000 for the same period a year ago. In addition to the business expansion, the increase in operating expenses was attributable to a $0.2 million increase in G&A expenses associated with increased R&D related to oxygen and respiratory products, and, expenses associated with being a publicly traded company, including costs of maintaining and enhancing our internal controls, and a $0.1 million increase in selling expenses for marketing and network building.

Net IncomeNet income attributable to the Company for the three months ended June 30, 2011 was $1.7 million, compared with $1.1 million for the three months ended June 30, 2010. The increase in net income was primarily due to robust top line growth. Earnings per diluted share were $0.39, based on 4.5 million shares outstanding for the quarter, compared with diluted EPS of $0.27, based on 4.3 million shares outstanding for the second quarter of 2010.

Liquidity and Capital ResourcesAs of June 30, 2011, Dehaier had $3.0 million in cash and cash equivalents, compared with $5.9 million as of December 31, 2010. The decrease was primarily to the result of an increase in prepayments due to more distribution agreements requiring prepayment for products. Current assets totaled $39.0 million, with working capital of $25.1 million and total shareholders' equity of $27.0 million at June 30, 2011, respectively.

Conference Call and WebcastManagement will host a conference call to discuss these financial results on Monday, August 15, 2011 at 8:00 a.m. EDT.

To participate in the call please dial (877) 941-8416 in the U.S. and Canada, or (480) 629-9808 for international calls, approximately 10 minutes prior to the scheduled start time. Interested parties can also listen via a live Internet webcast, which can be found on the Company's website at http://www.china
'/>"/>

SOURCE Dehaier Medical Systems Ltd. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. Dehaier Medical to Report Second Quarter 2011 Financial Results on August 15
2. Dehaier Opens First Oxygen Filling Facility and First Service Center for Home Oxygen Therapy Service in Beijing
3. Dehaier Medical Systems Names Dr. Xiaoqing Wang New Chief Technology Officer
4. Dehaier Strengthens Intellectual Property Portfolio
5. Dehaier Awarded $1.32 Million Procurement Contract to Supply Medical Devices to Hospital 301 in Beijing
6. Dehaier Medical Announces First Quarter 2011 Financial Results
7. Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
8. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
9. Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators
10. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results
11. Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7